In a major milestone in the treatment of stroke patients, the first comprehensive private sector Emergency Acute Stroke and Rapid Evaluation Center has opened in Imo State, Nigeria. The Center is the result of a cooperation between Regions Stroke and Neuroscience Hospitals, Labrad Diagnostics Center, and Regions Stroke and Epilepsy …
Read More »CDC warns of Listeria outbreak linked to peaches, nectarines, and plums
Key Points: Eleven people infected with the outbreak strain of Listeria have been reported from seven states. Ten people have been hospitalized and one person has died. Interviews with sick people and laboratory findings show that whole peaches, nectarines, and plums distributed by HMC Farms are making people sick. HMC …
Read More »CDC and FDA Expedite the Availability of Additional Doses of new RSV Immunization for Infants
Recently, CDC announced the release of more than 77,000 additional doses of Beyfortus™ (nirsevimab-alip (100 mg), a long-acting monoclonal antibody designed to protect infants against severe respiratory syncytial virus (RSV) disease. These additional doses will be distributed immediately to physicians and hospitals through the Vaccines for Children Program and commercial channels …
Read More »Global measles threat continues to grow as another year passes with millions of children unvaccinated
Following years of declines in measles vaccination coverage, measles cases in 2022 have increased by 18%, and deaths have increased by 43% globally (compared to 2021). This takes the estimated number of measles cases to 9 million and deaths to 136,000 – mostly among children – according to a …
Read More »CDC releases revised guidelines for the prevention and treatment of anthrax
Anthrax continues to occur in certain places around the world, with an estimated 20,000–100,000 cases occurring annually. Bacillus anthracis is considered the most likely bioweapon to be used during a bioterrorist event. To help protect the public’s health, CDC has published updated recommendations for the prevention and treatment of anthrax. …
Read More »More Than One in Three Americans are at Increased Risk for Type 2 Diabetes, but Changing the Outcome is Possible
Prediabetes is reversible, and the Centers for Disease Control and Prevention (CDC) and the Ad Council want to make sure people know they can change the outcome. More than 1 in 3 adults – about 98 million Americans — has prediabetes, and 81% of them don’t know they have …
Read More »CDC Recommends Updated COVID-19 Vaccine for Fall/Winter Virus Season
CDC recommends everyone 6 months and older get an updated COVID-19 vaccine to protect against the potentially serious outcomes of COVID-19 illness this fall and winter. Updated COVID-19 vaccines from Pfizer-BioNTech and Moderna will be available later this week. Vaccination remains the best protection against COVID-19-related hospitalization and death. Vaccination …
Read More »New Funding Opportunity to Strengthen Outbreak Response through Data, Forecasting, and Analytics
The Centers for Disease Control and Prevention (CDC) launched a new Notice of Funding Opportunity (NOFO) through the Center for Forecasting and Outbreak Analytics (CFA) to establish an outbreak response network for disease forecasting to support decision-makers during public health emergencies. The NOFO establishes a new program via a cooperative …
Read More »Walensky announces departure from CDC Director launched widest-reaching reforms in decades to strengthen CDC operations, restored agency morale
CDC Director Dr. Rochelle Walensky announced today her intention to depart the agency at the end of June. Walensky has led CDC through a transition to greater normalcy across the country, after two years of COVID-19-related closures and waves of dangerous, new virus variants. She also launched Moving Forward – …
Read More »Bioventure, Minapharm Pharmaceuticals, and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa
Bioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH , a Berlin-based pharmaceutical company, announced today the signing of an exclusive license agreement for the commercialization of multiple biosimilar candidates developed and manufactured by Alvotech, in Egypt and eighteen additional countries in Africa and …
Read More »